Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model
- PMID: 15049512
- PMCID: PMC11529958
- DOI: 10.1023/b:cemn.0000012726.43842.d2
Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model
Abstract
1. Failure of anticonvulsive drugs to prevent seizures is a common complication of epilepsy treatment known as drug-refractory epilepsy but their causes are not well understood. It is hypothesized that the multidrug resistance P-glycoprotein (Pgp-170), the product of the MDR-1 gene that is normally expressed in several excretory tissues including the blood brain barrier, may be participating in the refractory epilepsy. 2. Using two monoclonal antibodies against Pgp-170, we investigated the expression and cellular distribution of this protein in the rat brain during experimentally induced epilepsy. Repeated seizures were induced in male Wistar rats by daily administration of 3-mercaptopropionic acid (MP) 45 mg/kg i.p. for either 4 days (MP-4) or 7 days (MP-7). Control rats received an equivalent volume of vehicle. One day after the last injection, rats were sacrificed and brains were processed for immunohistochemistry for Pgp-170. As it was previously described, Pgp-170 immunostaining was observed in some brain capillary endothelial cells of animals from control group. 3. Increased Pgp-170 immunoreactivity was detected in MP-treated animals. Besides the Pgp-170 expressed in blood vessels, neuronal, and glial immunostaining was detected in hippocampus, striatum, and cerebral cortex of MP-treated rats. Pgp-170 immunolabeled neurons and glial cells were observed in a nonhomogeneous distribution. MP-4 animals presented a very prominent Pgp-170 immunostaining in the capillary endothelium, surrounding astrocytes and some neighboring neurons while MP-7 group showed increased neuronal labeling. 4. Our results demonstrate a selective increase in Pgp-170 immunoreactivity in the brain capillary endothelial cells, astrocytes, and neurons during repetitive MP-induced seizures. 5. The role for this Pgp-170 overexpression in endothelium and astrocytes as a clearance mechanism in the refractory epilepsy, and the consequences of neuronal Pgp-170 expression remain to be disclosed.
References
-
- Abbot, M. J., and Romero, I. A. (1996). Transporting therapeutics across the blood brain barrier. Mol. Med. Today2:1106-113. - PubMed
-
- Biedler, N., and Riehm, W. (1990). Cellular resistance to actinomycin D hamster cells in vitro. Cross resistance, radioautographic, and cytogenetics studies. Cancer Res.30:1174-1184. - PubMed
-
- Campbell, L., Abulrob, A. N., Kandalaf, L., Pumer, S., Hollins, A., Gibbs, A., and Gumbleton, M. (2003). Constitutive expression of P-glycoprotein in normal lung alveolar epithelium and functionally in primary alveolar epithelial cultures. J. Pharmed. Exp. Ther.304:441-452. - PubMed
-
- Comerford, K. M., Wallace, T. J., Karhausen, J., Louis, N. A., Montalto, M. C., and Colgan, S. P. (2002). Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res.62:3387-94. - PubMed
-
- De Sarro, G., Ferreri, G., Gareri, P., Russo, E., De Sarro, A., Gitto, R., and Chimirri, A. (2003). Comparative anticonvulsant activity of some 2,3-benzodiazepine derivates in rodents. Pharmacol. Biochem. Behav. 74:595-602. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous